Bangladesh Journal of Pharmacology

Dear Authors: The server is UPGRADING with the recent version of the OJS software. Submission of manuscript is not working temporarily. Please wait for a few days. We are sorry for your inconvenience. Authors may submit their manuscript to dgdabd@gmail.com directly until the software upgrading is completed. 

The Bangladesh Journal of Pharmacology (Bangladesh J Pharmacol) is an open-access, video component, and peer-reviewed biomedical science journal of the Bangladesh Pharmacological Society (BDPS).

_______________________________________________________________________________________

Beware of a clone version of BANGLADESH JOURNAL OF PHARMACOLOGY !

There is a fraudulent website claiming to act on behalf of Bangladesh Journal of Pharmacology started on May 21, 2025. It is listed as a Hijacked journal (The Retraction Watch Hijacked Journal Checker – Retraction Watch) .

How to identify it:

a) Type "Bangladesh Journal of Pharmacology" in any search engine (such as Google.com). The URL is other than https://banglajol.info/index.php/BJP or https://bdpsjournal.org/index.php/bjp.

b) No names of Editor-In-Chief, Editorial Board Members, and no Authors guidelines.

c) Does not provide any DOI number of each article (important for all articles).

d) Motivate to publish your paper as RAPID PUBLICATION

e) They provide FAKE ACCEPTANCE LETTER

f) Receive money from authors as article processing charge (APC). Special rate (higher) for the Chinese/Saudi authors. Transaction with a bank account located in India instead of Bangladesh. They use personal account name instead of "Bangladesh Pharmacological Society" name.

g) Publishes papers on chemistry, biology and public health (unrelated to journal title). Within the last 110 days, they published 40 papers of any type (including Law, Business, Computer science) of which 29 were withdrawn by the authors. Other authors failed to withdraw their papers as the hijacked journal authority claimed extra money from the authors as Withdrawal fee.

Solution:

Please don't fall on this trap. Otherwise, you will, no doubt, lose your money, get stress, and lose your reputation to your institute/colleagues. We have constant observation on this fraudulent website.

If you have any question, please write to us directly (dgdabd@gmail.com). Your name and email address will not be disclosed publicly.

__________________________________________________________________________________________

Aims and Scope: The journal publishes papers on the studies of plant extracts or drugs on pharmacological effects, using laboratory animals, human cell lines, and microbes.

The papers are Research Articles, Mini-reviews, Meta-analyses, Clinical Trials, Visual Experiments, and Letters to the Editor. Those who want to publish a research article must submit a video clip of one of the methodologies. Mini-reviews and Meta-analyses are usually unsolicited. A letter to the Editor is okay if the author(s) have data that is slightly different from published data.

The studies on antihypertensive drugs, anti-HIV agents, molecular docking without the data from the wet lab, nanotechnology, and polyherbal products are not within the scope of this journal.

The journal publishes four online issues (January, April, July, and October) per year.

Journal Metrics
Journal metrics allow you to compare journals, regardless of their subject classification.
Impact Factor^® as reported in the 2022 Journal Citation Reports^®: 1.6

CiteScore (2021): 2.0  Current month's CiteScore Tracker
H index (2023): 30 (It means 30 articles of this journal have more than 30 citations)

Abstracted/Indexed in
Academic Search Complete, Bangladesh Journals Online, Biological Abstracts, BIOSIS Previews, CAB Abstracts, Current Abstracts, Directory of Open Access Journals, EMBASE/Excerpta Medica, Global Health, Google Scholar, HINARI (WHO), International Pharmaceutical Abstracts, Open J-gate, Science Citation Index Expanded, SCOPUS and Social Sciences Citation Index

Members
Bangladesh Journal of Pharmacology is a member of OASPA (Open Access Scholarly Publishers Association), COPE (Committee on Publication Ethics), the International Society of Managing and Technical Editors (ISMTE) and the Asian Council of Science Editors.